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Abstract: The present study aimed to monitor the practices of Algerian veterinarians in the diagnosis and treatment of puerperal
metritis (PM) and clinical endometritis (CE) in cattle. For this purpose, a questionnaire was established and distributed to collect the
information concerning veterinarian profiles and practices related to the diagnosis and treatment of PM and CE. The results showed
that examinations of the uterus (rectal palpation), vaginal discharge, and rectal temperature were the most practiced methods for PM
(71%, 68%, and 83%, respectively) and CE (86%, 60%, and 65%, respectively) diagnosis. Tetracycline was the antibiotic of choice for
intrauterine treatment of PM (54%) and CE (57%), whereas penicillin was the preferred parenteral antibiotic against PM (68%) and CE
(64%). In addition, molecules combined with antibiotic treatment were PGF2α (PM: 71%, CE: 79%), vitamins (PM: 73%, CE: 60.5%),
and nonsteroidal antiinflammatory drugs (PM: 68.2%, CE: 58%). Inseminators were more likely to use IU cephalosporins to treat PM
and CE (OR = 3.5, P < 0.05 and OR = 5.1, P < 0.01, respectively). Veterinarians with more than 10 years of experience were more likely
to use IU cephalosporins to treat PM (OR = 3.8, P = 0.03). Moreover, bovine practitioners were less likely to observe hyperthermia in
cases of CE (OR = 0.29, P = 0.02).
Key words: Puerperal metritis, clinical endometritis, survey

1. Introduction
Postpartum uterine infections (PPUIs) are considered
as one of the main pathologies causing infertility of the
cow and its culling [1–5]. They are the outcome of the
combination of a determining factor, pathogens (bacteria),
and predisposing factors (e.g., retained placenta and
hypocalcemia) [6,7].
Clinically, PPUIs were divided into four forms [8].
First, puerperal metritis (PM), with a prevalence of 15%–
20% [9], occurs within 21 days postpartum and can be
diagnosed based on an abnormal distension of the uterus
combined with a fetid watery red-brown uterine discharge
and systemic symptoms. When the systemic symptoms
are absent, this form of PPUI is called clinical metritis [8].
Second, clinical endometritis (CE) is observed more than
21 days postpartum and can be diagnosed by the presence
in the vagina of mucopurulent or purulent uterine
discharge [8,10], with a prevalence between 5% and 26%
[11]. Third, subclinical endometritis is characterized by
the absence of clinical symptoms, cytology analyses being

the only tool for its diagnosis [8]. Fourth, pyometra, a
rare condition comprising fewer than 5% of cases of PPUI
[7], is defined by the accumulation of purulent material
within the uterine lumen with a closed cervix [8]. With a
high prevalence, the possibility of clinical diagnosis, and
important economic losses, PM and CE are the PPUIs
most often confronted and treated by veterinarians in the
field.
A large variety of therapeutic agents have been
proposed for the treatment of PM and CE. These treatments
are based on the intrauterine administration of antibiotics
(tetracycline, cephapirin) [12,13] and antiseptics (iodine
solutions) [14] and the parenteral administration of
antibiotics (penicillin, ampicillin, ceftiofur) [15–18],
hormones (prostaglandin F2α) [18,19], and supportive
therapy (nonsteroidal antiinflammatory drugs and sera)
[20,21]. Due to the diversity of molecules proposed to treat
PM and CE and the absence of conventional treatment,
different treatment approaches may exist in the field.
However, little is known about the state of PM and CE and
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their management in field conditions. To our knowledge,
the study of Hehenberger et al. [22] in Switzerland was the
only survey that was carried out to determine practices of
veterinarians in the field in dealing with PM and CE.
In this respect, the practices of veterinarians in Algeria
toward PM and CE remain unknown. Thus, the objective
of the current work was to study the practices of Algerian
veterinarians regarding diagnosis and treatment of PM
and CE in field conditions, including the influence of
veterinarian experience, practice of artificial insemination,
and number of bovine farms managed on those practices.
2. Materials and methods
2.1. Questionnaire
Collection of information on the practices of veterinarians
toward PM and CE was carried out using a questionnairebased survey. The questionnaire was divided into
three sections. The first section was designed to collect
information about veterinarians and their activities,
including sex, years of experience, main activity, number
of bovine farms visited, average number of cows per
farm, and whether the veterinarian practices artificial
insemination. The second and third sections included
multiple-choice questions about diagnosis and treatment
of PM and CE. For each choice, veterinarians were invited
to indicate the frequency of application on a Likert scale
(very frequently (more than 80% of cases), frequently
(40% to 80% of cases), sometimes (10% to 40% of cases),
rarely (1% to 20% of cases), or never (<1% of cases)). The
questionnaire was formatted using Google forms and
submitted to five practicing veterinarians for assessment.
The questionnaire was then distributed as electronic or
paper copies to 600 veterinarians. The electronic copies
were sent by e-mail to veterinarians affiliated with the
National Center for Artificial Insemination and Genetic
Improvement (CNIAAG) and the Algerian Veterinary
Technical Group (GTVA), whereas the paper copies
were distributed by hand on the occasion of professional
veterinary meetings.
2.2. Data analysis
The recovered data were loaded into a statistical package
(IBM SPSS 20; IBM Corp., Armonk, NY, USA) for
statistical analysis.
For descriptive statistics, the frequencies of application
of diagnosis and treatment of PM and CE were presented
as ordinal variables on a scale from 1 (never) to 5 (very
frequently).
Logistic regression was performed to show the
influence of factors (veterinarians’ characteristics) on
outcome variables (frequency of using diagnostic and
therapeutic approaches towards PM and CE). The
outcome variables were regrouped into 2 categories: (i)
frequent use (regrouping the modalities of frequently and

very frequently) and (ii) infrequent use (sometimes, rarely,
and never). Factors were regrouped as follow: years of
experience (<10 years, >10 years), main practice (bovine
vs. other species), number of bovine farms managed (>50
farms vs. <50 farms), and practice of artificial insemination
(yes vs. no).
For univariate regression, chi-square analyses were
performed between each predictor and each outcome
variable. When P < 0.05, a univariate regression was
considered and calculation of the odds ratio (OR) and 95%
confidence interval (CI) was carried out.
For multivariate regressions, the variables with a P-value
of <0.2 from the univariate regression were included in a
series of backward stepwise logistic regressions to obtain a
minimal model containing only significant variables (P <
0.05) and the OR and 95% CI were calculated to assess the
strength of the relationship between two or more factors
and one outcome variable.
3. Results
One hundred and sixteen questionnaires were completed,
representing 18.2% of the total surveyed veterinarians.
3.1. General characteristics of the veterinarians
The results revealed that 58.6% (68/116) of veterinarians
had more than 10 years of experience. The percentages
of veterinarians practicing bovine medicine and artificial
insemination were 65.1% (69/106) and 57.4% (66/115),
respectively. In addition, 53% (61/115) of veterinarians
monitored 50 or more bovine herds.
3.2. Descriptive results
3.2.1. Diagnosis of PM
The results on diagnosis showed that 83.5% (81/97) of
veterinarians measure, frequently or very frequently, body
temperature. Moreover, 71.8% (74/103) of the veterinarians
perform transrectal examination by hand, frequently or
very frequently, to diagnose PM, while only 17.1% (13/76)
do it by echography. A fetid discharge and fever were
observed, frequently or very frequently, by 91.0% (101/111)
and 83.5% (86/103) of surveyed veterinarians, respectively.
More than 60% of veterinarians observe, frequently or
very frequently, an appetite loss (74.5%, 70/94), a decrease
in milk production (69.4%, 68/98), or a distended uterus at
rectal examination (64.0%, 57/89) (Figure 1).
3.2.2. Treatment of PM
The results of PM treatment are given in Tables 1 and 2.
They revealed that intrauterine (IU) treatment, mainly
antibiotics, was applied, frequently or very frequently,
by 76.4% (55/72) of veterinarians. Tetracyclines are
used, frequently or very frequently, by 72.2% (70/97)
of veterinarians. Penicillin-streptomycin association is,
frequently or very frequently, selected by 53.4% (47/88) of
surveyed veterinarians. Cephalosporins are used by 32.5%
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Fetid vaginal mucus (n = 111)

80

Fever (n = 103)
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Appetite loss (n = 94)
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Very frequent (> 80% of cases)
Frequent (40-80% of cases)

Decrease in milk production (n = 98)

43

Distended uterus at rectal exam (n = 89)

38

Depression (n = 88)
Dehydratation (n = 84)
Recombency (n = 84)
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30
3

23
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4
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3

Never (<1% of cases)
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21
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Figure 1. Frequency distribution of the symptoms of PM from the perspective of the responding veterinarians, n = number
of responses.
Table 1. Frequencies of the intrauterine drugs used in cows with PM.
Treatment

Very frequent
(>80% of cases)

Frequent (40%–
80% of cases)

Sometimes (10%–
40% of cases)

Rarely (1%–
10% of cases)

Never
Number of
(<1% of cases) respondents

Tetracycline

53.6%

18.6%

12.4%

8.2%

7.2%

97

Penicillin-streptomycin

38.6%

14.8%

5.7%

13.6%

27.3%

88

Uterine lavage

20.0%

15.3%

16.5%

14.1%

34.1%

85

Cephalosporin

20.5%

12.0%

19.3%

8.4%

39.8%

83

Potassium permanganate

14.8%

7.4%

17.3%

14.8%

45.7%

81

Penicillin

13.2%

15.8%

14.5%

11.8%

44.7%

76

Iodine solution

7.5%

7.5%

11.3%

17.5%

56.3%

83

Aminoglycoside

2.9%

7.2%

7.2%

8.7%

73.9%

69

Rifaximin

00.0%

4.4%

7.4%

82.4%

5.9%

68

Table 2. Frequencies of parenteral antibiotics used by veterinarians in cases of PM.
Treatment

Very frequent
Frequent
Sometimes
Rarely
Never
Number of
(>80% of cases) (40%–80% of cases) (10%–40% of cases) (1%–10% of cases) (<1% of cases) respondents

Penicillins

42.9%

25.0%

20.2%

3.6%

8.3%

84

Tetracyclines

10.3%

7.4%

4.4%

7.4%

70.6%

80

Cephalosporin

36.4%

14.3%

6.5%

6.5%

36.4%

77

Macrolides

27.5%

20.0%

17.5%

8.8%

26.3%

80

Sulfamides

15.5%

12.7%

23.9%

15.5%

32.4%

71

Aminoglycosides

6.2%

13.8%

13.8%

12.3%

53.8%

65

Quinolones

4.7%

7.8%

12.5%

12.5%

62.5%

64

Phenicols

0%

3.0%

6.1%

9.1%

81.8%

66
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3.2.4. Treatment of CE
In the case of CE presenting with mucopurulent or
purulent discharge, an association between general and
intrauterine treatments was frequently or very frequently
established by 64.1% (66/103) and 71.3% (72/101) of
veterinarians, respectively.
PGF2α is used by 78.6% (77/98) of veterinarians
frequently or very frequently to treat CE and it is used even
in the absence of a corpus luteum by 56.5% (61/108) of
veterinarians.
Intrauterine administration of antibiotics is carried
out by 87% of veterinarians. Tetracycline and penicillinstreptomycin association are used frequently or very
frequently by 57% (49/86) and 58% (51/88) of veterinarians,
respectively. Cephalosporins are used frequently or very
frequently by 40.5% (32/79) of veterinarians (Table 3).
The systemic administration of antibiotics is used
systematically by 53.3% of veterinarians to treat CE.
Parenteral penicillins were systemically applied frequently
or very frequently by 64.4% (58/90) of veterinarians,
whereas macrolides and cephalosporins were frequently
or very frequently injected by 49.4% (40/83) and 48.2%
(40/83) of practitioners, respectively (Table 4).

(27/83) of veterinarians frequently or very frequently.
In addition, 48.2% (41/85) of responding veterinarians
perform uterine lavage rarely or never to treat PM. Iodine
solution, aminoglycosides, and penicillins are rarely or
never used.
Concerning parenteral administration of drugs, 80%
of veterinarians perform, frequently or very frequently,
parenteral antibiotherapy. Penicillins, tetracyclines, and
cephalosporins are, frequently or very frequently, used
by more than 50% of veterinarians (Table 1). Macrolides
are also injected, frequently or very frequently, by 47.5%
(38/80) of veterinarians. Quinolones and phenicols are
rarely or never used. Veterinarians included supporting
therapy frequently or very frequently, particularly vitamins
(73.1%, 68/93), PGF2α (61.4%, 75/105), and nonsteroidal
antiinflammatory drugs (68.2%, 60/88).
3.2.3. Diagnosis of CE
Visual examination of vulvar discharge and rectal palpation
are performed to diagnose CE frequently or very frequently
by the majority of the veterinarians (91.3%, 94/103 and
86.7%, 85/98, respectively). Moreover, monitoring body
temperature and vaginal examination by gloved hand are
performed frequently or very frequently by 65.1% (54/83)
and 60.9% (56/92) of veterinarians, respectively.
The results revealed that most veterinarians do not use
a vaginoscope or a speculum frequently or very frequently
(29.8% and 17.5%, respectively). Furthermore, 97% of
veterinarians never use a laboratory.
Pus flakes and mucopurulent vaginal discharge are
observed frequently or very frequently by 76.7% (79/103)
and 75.8% (75/99) of veterinarians, respectively. Half of
veterinarians observe general symptoms and a distended
uterus in rectal examination (60.2% (56/93), 55.1%
(49/89), respectively) (Figure 2).

Discharge with purulent flakes (n = 103)

3.3. Univariate analysis
The results of univariate analysis are presented in Tables
5 and 6.
3.3.1. Puerperal metritis
Compared to veterinarians whose main activity was not
bovine medicine, bovine practitioners (main activity was
bovine medicine) were 3 times more likely to practice
palpation of the uterus (83.6% vs. 61.8%, P = 0.022) and
4.8 times less likely to observe an elevation of temperature
(75.8% vs. 93.5%, P = 0.037) for diagnosis of PM. They were
also 4.5 times less likely to use IU tetracycline (61.4% vs.

30

49

Mucopurulent discharge (n = 99)

41

Purulent discharge (n = 94)

40

General symptoms (n = 93)

34

Fever (n = 88)

33

Distanded uterus in rectal exam (n = 89

29
0%

34
21

19

11

20

10
20
50%

28

5

19

5
10 4
6

12

19

22

19

Very often (> 80% of cases)
Frequent (40-80% of cases)
Sometimes (10-40% of cases)
Rarely (1-10% of cases)
Never (<1% of cases)

14
10 2
100%

Figure 2. Frequency distribution of the symptoms of CE from the perspective of the responding veterinarians, n = number
of responses.
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Table 3. Frequencies of the intrauterine drugs used in cows with CE.
Treatment

Very frequent
Frequent (40%– Sometimes (10%– Rarely (1%–
(>80% of cases) 80% of cases)
40% of cases)
10% of cases)

Never
(<1% of cases)

Number of
respondents

Tetracycline

43.0%

14.0%

11.6%

10.5%

20.9%

86

Penicillin-streptomycin

39.8%

18.2%

13.6%

3.4%

25.0%

88

Cephalosporin

34.2%

6.3%

19.0%

5.1%

35.4%

79

Uterine lavage

20.0%

15.0%

12.5%

15.0%

37.5%

80

Potassium permanganate

18.4%

11.8%

13.2%

11.8%

44.7%

Penicillin

16.2%

21.6%

14.9%

8.1%

39.2%

76
74

Other

6.2%

7.7%

9.2%

12.3%

64.6%

65

Diluted betadine

4.1%

13.7%

16.4%

13.7%

52.1%

73

Aminoglycosides

5.8%

8.7%

13.0%

5.8%

66.7%

69

Rifaximin

0%

1.4%

5.8%

15.9%

76.8%

69

Table 4. Frequencies of parenteral antibiotic therapy used in cows with CE.
Treatment

Very frequent Frequent
Sometimes
Rarely
Never
Number of
(>80% of cases) (40%–80% of cases) (10%–40% of cases) (1%–10% of cases) (<1% of cases) respondents

Penicillins

38.9%

25.6%

13.3%

7.8%

14.4%

90

Tetracycline

33.3%

27.3%

9.1%

6.1%

24.2%

33

Cephalosporin

32.5%

15.7%

8.4%

12.0%

31.3%

83

Association

31.9%

18.1%

20.8%

9.7%

19.4%

72

Macrolides

25.9%

23.5%

14.8%

9.9%

25.9%

81

Sulfamides

13.2%

11.8%

23.7%

9.2%

42.1%

76

Aminoglycosides

7.2%

14.5%

15.9%

15.9%

46.4%

69

Quinolones

5.9%

8.8%

11.8%

13.2%

60.3%

68

Phenicols

1.5%

3.0%

6.1%

7.6%

81.8%

66

87.5%, P = 0.009), 3.4 times more likely to use parenteral
cephalosporins (64.4% vs. 34.8%, P = 0.02), and 3.1 times
less likely to use vitamins to treat PM (65.5% vs. 85.4%, P
= 0.05).
Veterinarians with more than 10 years of experience
were 2.7 times less likely to use intrauterine tetracyclines
(64.9% vs. 83.3%, P = 0.042) and 5.4 times more likely to use
IU cephalosporins (43.4% vs. 12.5%, P = 0.003) compared
to veterinarians with less than 10 years of experience.
Inseminators were 4.3 times less likely than those not
practicing insemination to take body temperatures (75.5%
vs. 93.0%, P = 0.019) and to observe fever (76.8% vs.
93.5%, P = 0.021). Inseminators were also 4.7 times more
likely to use IU cephalosporins (44% vs. 14.3%, P = 0.004),
5.6 times more likely to not use systemic treatment (27%
vs. 6.25%, P = 0.023), 4.3 times less likely to use systemic
penicillin (52.3% vs. 82.9%, P = 0.003), and 2.5 times more
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likely to use systemic cephalosporins (60.1% vs. 38.9%, P
= 0.053).
In comparison with those monitoring fewer than 50
bovine farms, veterinarians monitoring more than 50
farms were 3.1 times less likely to use IU tetracycline (62%
vs. 83.7%, P = 0.015), and 3.8 times more likely to use IU
cephalosporin (42.6% vs. 16.2%, P = 0.01). They were also
2.6 times less likely to use parenteral macrolides (35.6% vs.
61.1%, P = 0.022).
3.3.2. Clinical endometritis
When compared to noninseminators, inseminators were
4.7 times more likely to use echography (37.0% vs. 11.1%,
P = 0.008) and 2.9 times more likely to use a vaginoscope
(37.5% vs. 17.1%, P = 0.043) to diagnose CE. They were
also 2.5 times less likely to observe fever (38.3% vs. 61%, P
= 0.034) and 2.5 times less likely to observe an alteration
of the general state of the cow (50.0% vs. 72.5%, P = 0.029).
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Table 5. Summary of the results of a univariate logistic regression with statements regarding diagnosis and
treatment PM.
Parameter

Bovines as main activity

P

Palpation of the uterus

3.03 (1.15–8.00)

0.022

Fever

0.21 (0.046–1.01)

0.037

Intrauterine tetracycline

0.22 (0.07–0.73)

0.009

3.40 (1.19–9.74)

0.02

0.32 (0.1–1.04)

0.05

Practice of AI

P

Taking rectal temperature

0.23 (0.06–0.85)

0.019

Fever

0.23 (0.06–0.86)

0.021

No parenteral antibiotics

5.55 (1.12–27.65)

Intrauterine cephalosporin
Parenteral cephalosporin

>10 years of experience

P

0.37 (0.14–0.98)

0.042

5.37 (1.65–17.47)

0.003

>50 herds

P

0.32 (0.12–0.82)

0.015

3.84 (1.34–10.91)

0.01

0.35 (0.14–0.87)

0.022

Parenteral macrolide
Vitamins
Palpation of the uterus

Intrauterine tetracycline
Parenteral tetracycline

0.4 (0.16–0.97)

0.042

Intrauterine cephalosporin

4.71 (1.57–14.15)

0.004

Parenteral cephalosporin

2.46 (0.98–6.15)

0.053

Parenteral penicillins

0.23 (0.082–0.62)

0.003

Parenteral macrolides

Table 6. Summary of the results of the univariate logistic regression model for statements regarding the diagnosis and
treatment of CE.
Parameter

Bovines as main activity

P

Rectal temperature

0.29 (0.1–0.84)

0.019

Fever

0.23 (0.09–0.61)

0.003

Distended uterus

>10 years of experience

P

0.44 (0.18–1.03)

0.056

2.52 (1.06–5.97)

0.034

3.16 (1.21–8.28)

0.017

2.33 (1.06–5.10)

0.033

>50 herds

P

Intrauterine tetracycline

0.30 (0.11–0.80)

0.014

Intrauterine cephalosporin

4.17 (1.41–12.34)

0.008

Parenteral antibiotics systematically

0.40 (0.17–0.96)

0.037

Practice of AI

P

Echography

4.69 (1.41–15.56)

0.008

Vaginoscopy

2.90 (1.01–8.33)

0.043

Fever

0.4 (0.17–0.94)

0.034

0.28 (0.12–0.67)

0.004

Alteration of the general state

0.38 (0.16–0.92)

0.029

0.30 (0.13–0.74)

0.007

0.34 (0.14–0.83)

0.017

PGF2α without corpus luteum

Intrauterine tetracycline
Intrauterine cephalosporin

8.70 (2.84–26.69)

<0.001

2.60 (1.01–6.70)

0.046

Parenteral antibiotics systematically

0.31 (0.14–0.70)

0.004

0.35 (0.16–0.79)

0.01

Parenteral macrolides

0.38 (0.15–0.94)

0.034

Parenteral vitamins

0.2 (0.08–0.52)

0.001
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Furthermore, inseminators were 3.2 times less likely to use
parenteral antibiotics systematically (40.7% vs. 68.9%, P =
0.004) and 8.7 times more likely to use IU cephalosporin
for CE treatment (60.0% vs. 14.7%, P < 0.001).
Bovine practitioners were 3.4 times less likely to
measure body temperature (51.1% vs. 78.6%, P = 0.019)
and 4.3 times less likely to observe fever (32.7% vs. 67.9%,
P = 0.003). They were also 3.3 times less likely to use IU
tetracycline (41.3% vs. 70.0%, P = 0.014), 2.5 times less
likely to use parenteral antibiotics systematically (41.3%
vs. 63.6%, P = 0.037), and 4 times more likely to use IU
cephalosporins (55.6% vs. 23.1%, P = 0.008) for CE
treatment.
Veterinarians with more than 10 years of experience
were 2 times less likely to observe fever (40% vs. 60.5%, P
= 0.056) and 3 times more likely to note a distended uterus
(64.7% vs. 41.7%, P = 0.034). They were 3 times more likely
to use IU cephalosporins (52.3% vs. 25.7%, P = 0.017)
and 2 times more likely to use PGF2α in the absence of a
corpus luteum (65.1% vs. 44.4%, P = 0.033).
Veterinarians monitoring more than 50 bovine farms
were 3.6 times less likely to observe fever (33.3% vs. 64.3%,
P = 0.004) and 3.3 times less likely to observe alteration of
the general state of the cow (46.9% vs. 74.4%, P = 0.007).
They were also 2.9 times less likely to use tetracyclines
(44.2% vs. 69.8%, P = 0.017) and 2.6 times more likely to
use IU cephalosporins (50.0% vs. 27.8%, P = 0.046). In
addition, they were 2.9 times less likely to use parenteral
antibiotics systematically (48.9% vs. 66.0%, P = 0.01), 2.6
times less likely to use systemic macrolides (39.1% vs.
62.9%, P = 0.034), and 5 times less likely to use vitamins
(43.5% vs. 79.5%, P = 0.001).
3.4. Multivariate analysis
Inseminators were 4 times more likely to use IU
cephalosporins to treat PM and 5 times more likely to
treat CE. Likewise, veterinarians with more than 10
years of experience were 4 times more likely to use IU
cephalosporins to treat PM. Moreover, bovine practitioners
were 3 times less likely to observe hyperthermia in cases of
CE (Table 7).

4. Discussion
The present survey was undertaken to investigate practices
of Algerian veterinarians in the diagnosis and treatment
of PM and CE. We hypothesize that factors related to the
experience of the veterinarians, their practice of AI, main
activity, and number of farms monitored may influence
their practices towards the uterine infections.
It was reported that clinical diagnosis of PM is based on
the presence of general and local signs including purulent
vaginal discharge, fever, appetite loss, decrease in milk
production, and distended uterus [8,10,23]. In our survey,
these signs were adopted by most veterinarians for PM
diagnosis. Moreover, the surveyed veterinarians indicated
that signs of intoxication are rarely present, which may
be related to early diagnosis before intensification of the
animal’s state and the appearance of signs of intoxication.
A similar survey conducted with Swiss veterinarians
reported the same results for PM diagnosis [22].
The use of systemic antibiotics is the conventional
treatment of PM [17,24]. In our study, the majority of
Algerian veterinarians used systemic antibiotics for PM.
A similar result was observed for Swiss practitioners
[22]. In the current survey, practitioners used penicillins
most often, followed by tetracyclines, cephalosporins,
and aminoglycosides. Likewise, in a study in Sweden, PM
was treated principally with penicillins and secondarily
with tetracyclines. In the same study, cephalosporins were
not used by veterinarians [25]. In this study, the choice
of the treatment was based on the recommendations of
the Swedish policy recommending penicillin as the first
choice antibiotic for PM [25]. Tetracyclines, however, were
the principal antibiotics reported by Swiss veterinarians
for PM treatment [13]. Different studies were conducted
to reveal the optimum antibiotics for PM. In this respect,
the efficiency of tetracycline and penicillins requires
their use at high concentrations, which enhances their
withdrawal periods in meat and milk [26]. Cephalosporin
is efficient at recommended doses. Furthermore, at the
recommended dose, high concentrations of cephalosporin
were observed in the serum, endometrium, caruncles,
cotyledons, and lochia with no withdrawal periods [26–

Table 7. Summary of the results of a series of multivariable logistic regression models for statements regarding the diagnosis and
treatment of PM and CE.
Parameter for PM

>10 years of experience

P

Practice of AI

P

Intrauterine cephalosporin

3.8(1.13–13.36)

0.031

3.5 (1.02–12.23)

0.046

Practice of AI

P

5.1 (1.58–16.84)

0.007

Parameter for CE

Bovines as main activity

P

>10 years of experience

P

Hyperthermia

0.29 (0.11–0.83)

0.02

0.26 (0.18–1.34)

0.16

2.8 (0.91–8.76)

0.072

Intrauterine cephalosporin

224

RAHAB et al. / Turk J Vet Anim Sci
28]. In order to show the antibiotics of choice for PM,
Smith et al. compared penicillin G and cephalosporin. No
difference in terms of cure was observed between the two
tested antibiotics [13]. Thus, cephalosporin seems more
appropriate for systemic treatment of PM. The lack of use
of cephalosporin in our study may be attributed to its price
and its relatively recent introduction to the field compared
to penicillins and tetracyclines. In our survey, bovine
practitioners and inseminators more frequently used
cephalosporins, which may be due to their more frequent
dealings with bovine pathologies including PM, allowing
the adoption of the appropriate treatment.
In the present survey, almost 80% of surveyed
veterinarians performed intrauterine treatment for
PM with tetracycline and to a lesser extent with
penicillin-streptomycin and cephalosporin, respectively.
Inseminators and veterinarians monitoring more than 50
bovine farms used more IU cephalosporin. In a similar
survey in Switzerland [22], the results revealed that more
than 90% of veterinarians performed intrauterine therapy
using tetracycline and cephalosporin, but not penicillinstreptomycin. Many studies showed beneficial effects
of IU use of oxytetracycline at high doses [9], but other
studies reported the noneffectiveness [13]. In addition it is
irritating to the endometrium and alters local immunity.
However, our survey, like that in Switzerland, revealed
that tetracyclines are still used by veterinarians for PM
treatment.
In association with antibiotics, several molecules are
used to reinforce the treatment for uterine infections.
Among these molecules, PGF2α and nonsteroid
antiinflammatory drugs are the most often implicated in
PM treatment. Regarding PGF2α, it is used for its luteolytic
effect, uterotonic nature, and leukocyte stimulation.
However, many studies reported no effect of PGF2α when
used to treat uterine infection. In our survey and that in
Switzerland, PGF2α was used systematically despite the
contradictory results concerning its effect. In cases of PM,
one study evaluated the use of PGF2α as a complementary
treatment to cephalosporin. It was concluded that 2 doses
of PGF2α were beneficial for primiparous cows having PM
but not for multiparous cows [29].
Concerning nonsteroid antiinflammatory drugs, the
Algerian veterinarians, like those of Switzerland [22],
frequently use them in association with antibiotics. The
use of nonsteroid antiinflammatory drugs in cases of PM
may be explained by the presence of fever. However, there
is a contradiction regarding the benefits of nonsteroid
antiinflammatory drugs in PM. Amiridis et al. showed
a more rapid uterine involution and onset of ovarian
activity in animals having PM treated by nonsteroid
antiinflammatory drugs (flunixin meglumine) in addition
to systematic antimicrobials [30]. On the contrary, other

studies found no superior effect when these drugs were used
in combination with antibiotics [31,32]. Further studies
are required to provide evidence-based medicine with the
proof about the use of nonsteroid antiinflammatory drugs
to treat PM.
Clinical endometritis is a uterine infection occurring
after 21 days postpartum, characterized by the presence
of purulent material in the vagina [8]. In the present
study, the surveyed veterinarians observed CE between
22 and 30 days postpartum. Furthermore, they frequently
observed local symptoms by visual exam of the vulvar
discharge and rectal palpation. Likewise, the survey in
Switzerland revealed that CE was diagnosed between 21
and 35 days postpartum by local symptoms. Moreover,
in this study, rectal palpation and vaginal examination
were the diagnostic tools used [22]. Previous clinical
studies reported that efficient tools for CE diagnosis are
detection of purulent material in the vagina by gloved
hand or vaginoscope and rectal palpation of the uterus
combined with external inspection of vulvar discharge
[11]. In the current survey, Algerian veterinarians used
rectal palpation of the uterus and external inspection
of vulvar discharge to diagnosis CE. Concerning Swiss
veterinarians, diagnosis is based on rectal palpation and
detection of purulent material in the vagina by gloved
hand. CE diagnosis tools adopted by Algerian and Swiss
veterinarians could be justified by their efficiency and
practicability, not requiring an instrument (vaginoscope).
In our survey as well as in the survey performed
in Switzerland [22], PGF2α is used by the majority of
veterinarians for treating CE. Previous studies showed
that PGF2α is efficient in the treatment of CE when a
corpus luteum exists. Thus, the purpose of inclusion
of PGF2α in CE treatment is to provoke luteolysis, the
apparition of estrus, and subsequent uterine contractility.
These processes lead to clearance of the uterine cavity.
Moreover, PGF2α improves the local immunity of the
uterus and the recovery of the physiologic uterine state
[33,34]. In addition, PGF2α was reported to be preferred
to antibiotics due to its null withdrawal period and its
lack of implication in the emergence of resistant bacteria
[35]. In cases of CE with absence of a corpus luteum,
several clinical trials showed conflicting results about the
efficiency of PGF2α [12,36,37]. In our survey, an important
part of the veterinarians used PGF2α in the absence of a
corpus luteum. Even in the absence of a corpus luteum,
PGF2α increases leukotriene B4 secretion by the uterus,
which supports chemotaxis, cell-mediated cytotoxicity,
phagocytosis, and lymphocyte function [34]. This may
justify its use by the surveyed Algerian veterinarians.
Intrauterine administration of antibiotics is considered
as the best approach for CE. This is because infection is
limited to the endometrium. In our study, tetracycline

225

RAHAB et al. / Turk J Vet Anim Sci
is used by most surveyed veterinarians. However, Swiss
veterinarians mainly used IU cephalosporin for CE [22].
The selection of tetracycline by Algerian veterinarians
may be attributed to its high endometrial concentration
and its poor absorption after intrauterine administration
[38]. However, bacteriological studies showed that a large
part of bacteria causing uterine infection are resistant
to tetracycline [39–44]. Cephapirin is reported as the
most appropriate antibiotic for treatment of CE and the
effectiveness of cephalosporin against uterine pathogens
was proven in vitro [39–44]. In addition, it has no
withdrawal period in milk and meat. In our study, the
multivariate analysis indicated that inseminators, whatever
their experience, used IU cephalosporin more frequently
to treat CE. This may indicate that inseminators are more
concerned about uterine health, which is a determinant
factor for the success of AI.
Systemic antibiotics are also used by Algerian
veterinarians (more than half) to treat CE. In the Swiss
survey, most of the veterinarians did not use systemic
antibiotics. It was reported that administration of

antibiotics within the uterus is efficient to treat CE without
a need for further systemic antibiotics. Furthermore, the
use of systemic antibiotics is costly and requires long
withdrawal period in milk. Thus, the parenteral use of
antibiotics in cases of CE by Algerian veterinarians is not
justified.
Finally, we conclude that the diagnoses of PM and CE
by surveyed veterinarians are close to the reported criteria.
However, a contradiction in the treatment for CE and PM
is observed, particularly in the use of IU antibiotics in
PM and PGF2 in the absence of a corpus luteum in CE.
Moreover, some antibiotics used are not reported in the
literature, like macrolides and penicillin-streptomycin
association. Inseminators seem more interested in looking
for recent advances about treatment of uterine infection
and updating their treatment approaches accordingly.
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